Liquor Impacting Brain Activity (Credit-Freepik)
Many of us believe that we are great drinkers and that alcohol does not affect us as much. People who are able to drink without showing any sign of inebriation are known as social drinkers. In short, they are not addicted to alcohol but will not turn down the opportunity to have a good time! While it may seem like it doesn’t affect you, new studies suggest that it is just an illusion, even if you have high tolerance, alcohol affects your cognitive and motor functions more than you think.
The study reveals the below implications and techniques:
Think of it as the foundation for your brain's performance. When brain conductivity is high, information flows smoothly, and that helps your brain in rapid processing and response. On the other hand, low conductivity can hinder cognitive function, leading to slower thinking, impaired memory, and difficulties with coordination.
A study conducted at the Neuroscience Research Australia (NeuRA) and UNSW Science unveiled a startling connection between alcohol consumption and brain conductivity.
While many people brush off the effects of alcohol as temporary changes in behaviour, the reality is much more complex. Beyond the obvious impacts on coordination and judgment, alcohol significantly alters brain function. Alcohol dramatically slowed down brain activity, especially in areas responsible for decision-making, planning, and physical coordination. This decline was so significant that it resembled the brain changes seen in normal ageing. This means even one drink could temporarily accelerate the ageing process of your brain.
The implications of this research are far-reaching. It provides compelling evidence that alcohol consumption has a direct and measurable impact on brain function. The discovery that alcohol can significantly reduce brain conductivity opens new avenues for understanding the neurocognitive effects of alcohol abuse and dependence. While you may not feel like alcohol is affecting you and you have a high tolerance, it most definitely changes and affects your decision-making abilities and impulse control.
Furthermore, the MRI technique employed in the study could be a valuable tool for assessing the impact of other substances on the brain and for developing interventions to mitigate alcohol-related brain damage.
Credit: iStock
In a world first, India's indigenous SSI Mantra Surgical Robotic System enabled two surgeons to perform a robotic beating-heart bypass procedure using a dual-console setup, according to SS Innovations.
The five-arm robotic system was used for a Totally Endoscopic Coronary Artery Bypass (TECAB) procedure by two surgeons from Medanta Hospital, Gurugram. The surgeons operated through separate control consoles while the patient's heart continued beating, without the use of a heart-lung machine.
They worked in synchrony using all five robotic arms. A heart stabilization system helped steady the target area during the procedure.
“The successful completion of this highly complex beating-heart TECAB procedure demonstrates how robotic surgery can make advanced cardiac interventions less invasive for patients. It is a proud moment for our team and an important step forward for cardiac surgery in India,” said Dr. Naresh Trehan, Chairman and Managing Director, Medanta.
Unlike conventional robotic cardiac procedures that typically use a single console, a dual-console configuration allows two surgeons to control the robotic system simultaneously. This can improve coordination during complex procedures.
The five-arm configuration allows multiple robotic instruments to be deployed at the same time. It also allows the second surgeon to gain hands-on experience during complex procedures, making the setup potentially useful for surgical training.
Totally Endoscopic Coronary Artery Bypass, or TECAB, is a minimally invasive form of bypass surgery performed through small incisions, without opening the chest through a conventional sternotomy.
In the beating-heart approach, surgeons perform the bypass while the heart continues beating, without stopping it or using a heart-lung machine. A stabilization system keeps the area being operated on steady.
Robotic cardiac surgery also avoids the extensive chest incision involved in conventional open-heart procedures.
The patient's recovery progress over 15 days offers an initial reference point for assessing the outcome. However, longer-term follow-up and clinical data would be needed to establish the broader benefits of this approach.
Dr. Nitin Kumar Rajput, Associate Director of Robotic and Minimally Invasive Cardiac Surgery at Medanta, said performing a complex beating-heart bypass using five robotic arms and two control consoles required precision, coordination and close collaboration between the surgeons.
“The patient's recovery following surgery was encouraging and reinforces the potential of minimally invasive techniques in advancing cardiac care,” he said.
The SSI Mantra is a modular surgical robotic system that can be configured with three to five arms. It features an ergonomic, open-faced Surgeon Command Centre, a 32-inch 3D 4K monitor and a 23-inch touchscreen for patient information.
The system also offers a real-time virtual view of the robotic arms and allows 3D models generated from diagnostic imaging to be superimposed.
Dr. Sudhir Srivastava, Founder, Chairman and CEO of SS Innovations International, Inc., said the procedure demonstrated the SSI Mantra system's potential in minimally invasive cardiac surgery and marked a major milestone for India's surgical robotics sector.
Credit: iStock
Amid rising antimicrobial resistance (AMR) worldwide, the Union Ministry of Health and Family Welfare has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, to bring antimicrobials under central regulatory oversight.
The amendment seeks to include ‘antimicrobials’ in the definition of ‘New Drug’ under Rule 2(1)(w)(v). Manufacturers would need central approval before applying for a manufacturing licence from state authorities.
"The proposal is intended to serve as an additional regulatory safeguard against antimicrobial resistance (AMR) by strengthening oversight of antimicrobial products and ensuring appropriate scrutiny of their quality, safety and efficacy before the grant of new manufacturing licences," the Ministry said.
AMR occurs when bacteria, viruses, fungi and parasites evolve and no longer respond to medicines designed to treat infections. This makes infections harder to treat, increases the risk of severe illness and death, and can complicate medical procedures such as surgery and cancer treatment.
Addressing the World Antimicrobial Resistance (AMR) Awareness Week 2026, Union Health Secretary Punya Salila Srivastava described AMR as one of the most serious public health challenges. She warned that misuse and overuse of antimicrobials could make even common infections difficult to treat and threaten decades of medical progress.
Also read: Antimicrobial Resistance Could Contribute To 39 Million Deaths By 2050: WHO
The Ministry proposed the amendment through draft Gazette Notification G.S.R. 983 (E), dated November 6.
Manufacturers would need permission from the Central Licensing Authority (CLA) before applying for a manufacturing licence from the concerned State Licensing Authority (SLA).
Existing manufacturing licences will remain valid, and holders will not need to reapply for permission.
The measure is expected to strengthen central oversight and help ensure the quality, safety and efficacy of antimicrobial products, the Ministry said.
The proposal follows concerns that antimicrobial manufacturing licences are being granted without adequate regulatory scrutiny, including bioavailability/bioequivalence (BA/BE) and stability studies.
The absence of these assessments may affect product quality, safety and efficacy. Substandard or ineffective antimicrobials can contribute to AMR and pose risks to patient safety.
"The measure is part of the Government's broader efforts to promote the responsible use of antimicrobials, safeguard patient safety and address the growing public health challenge of AMR," the Ministry said.
The amendment remains at the draft stage. The Ministry has invited objections and suggestions from stakeholders and the public before finalisation.
In addition, the Ministry has proposed amendments to the Drugs Rules, 1945, to introduce separate application and licence forms for the wholesale sale of bulk drugs, including active and inactive bulk substances.
Currently, a common licence covers the wholesale sale of both formulations and bulk drugs.
The proposed framework would allow more focused oversight of bulk drug sales and improve accountability in the pharmaceutical supply chain, the Ministry said.
Licences would specify the categories of bulk drugs handled by wholesalers, including those covered under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. Bulk drug sales would also require the personal supervision of a competent person.
Credit: iStock
The United States and other countries in the Americas are witnessing increasing influenza activity as the Northern Hemisphere enters the 2026–27 respiratory virus season.
In a November 17 epidemiological alert, the Pan American Health Organization (PAHO) and World Health Organization (WHO) urged countries to strengthen surveillance of respiratory viruses, prepare healthcare services for a possible increase in demand and accelerate seasonal influenza and respiratory syncytial virus (RSV) vaccination among priority groups before the peak of viral circulation.
The report noted that influenza, RSV and other respiratory viruses have gradually increased in the US. Overall respiratory virus activity is higher than typically observed at this time of year.
Influenza positivity increased from 7.6% in the week ending October 18 to 9.1% in the week ending October 25. Influenza A(H1N1)pdm09 emerged as the predominant subtype.
Influenza-like illness (ILI) activity was classified as high in two states, Louisiana and South Carolina. Hospital surveillance data also showed a gradual increase in influenza-associated hospitalisation rates.
Also read: US Respiratory Viruses In 2026: CDC Identifies 4 Illnesses To Watch
Canada is also witnessing an increase in influenza circulation, which began earlier than in previous post-pandemic seasons between 2022–23 and 2025–26.
Influenza positivity reached 10.8% in the week ending October 25, with activity shifting from low to moderate levels. Unlike the previous season, influenza A(H1N1)pdm09 is the predominant subtype.
COVID-19 circulation is also gradually increasing in Canada but remains low and below levels observed in previous seasons. SARS-CoV-2 positivity stood at 5.8%.
Hospitalisations associated with respiratory viruses are also rising, reaching 2.6 per 100,000 population. Influenza-associated hospitalisations reached 1.2 per 100,000, while the rate for COVID-19-associated hospitalisations was 1.3 per 100,000. However, PAHO/WHO noted that these rates remain low and within the expected range for this time of the season.
Read More: G155E H1N1 Mutation In US Raises Concerns: Can This Year’s Flu Shot Still Protect You?
Globally, influenza activity is following expected seasonal patterns, with a gradual increase over recent months in temperate and subtropical regions of the Northern Hemisphere. Influenza positivity in these regions is approaching 10%.
Some countries in North America, Central America and the Caribbean, as well as in Africa, Asia and Europe, have reported influenza positivity rates above 10%, according to the alert.
In contrast, influenza activity has declined over the past two months in temperate and subtropical regions of the Southern Hemisphere, where positivity has fallen to around 5%.
READ: Flu 2026: Symptoms To Watch For As New Season Begins
Alongside increasing influenza activity, PAHO/WHO highlighted high RSV circulation in some countries in the Northern Hemisphere.
Globally, RSV positivity rates above 10% were observed in some countries, particularly in tropical and subtropical regions.
The organization warned that the circulation of multiple respiratory viruses makes it important for countries to strengthen healthcare preparedness ahead of seasonal peaks.
PAHO/WHO has called on member states to strengthen integrated epidemiological and virological surveillance of respiratory viruses, including timely genomic characterization to monitor viral evolution.
It has also recommended that countries adjust healthcare preparedness and organizational plans in anticipation of a possible increase in demand for medical services.
The alert also urges countries to accelerate seasonal influenza and RSV vaccination among priority groups, in line with current recommendations and before periods of increased viral circulation.
© $2026 Times Horizon Private Limited